Data / Form D filings / Aqur Biosciences, Inc.
Aqur Biosciences, Inc.: Form D filing
Aqur Biosciences, Inc., a pharmaceuticals company in Westlake Village, CA, filed a Form D with the SEC in 2026. The latest, on September 18, 2026, reports $1.5 million sold of a $1.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2829 TOWNSGATE ROAD SUITE 100, Westlake Village, CA, 91361
- Phone
- (818) 698-1006
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2094075
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | New notice | $1,500,000 | $1,500,000 | 7 | Sep 3, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael A Fole | Executive Officer | |
| Jeffrey B Wolin | Executive Officer, Director | |
| James Hess Leach | Executive Officer | |
| Michel F Denarie | Executive Officer | |
| Tomi K Sawyer | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 14, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aqur Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.